SPAEN (Sarcoma Patients EuroNet) Presents Webinar

Webinar “Novel therapy options in GIST: What’s on the horizon?” was presented by Dr. Jonathan Trent, Professor of Medicine, Associate Director, Clinical Research Director, Sarcoma Medical Research Program Sylvester Comprehensive Cancer Center, University of Miami, Florida, USA, July 24, 2019. This webinar was sponsoted by SPAEN .

Dr. Jonathan Trent discussed common questions related to GIST as well as the importance of mutational testing and novel therapies that are on the horizon.

View Presentation

About the Presenter

Dr. Jonathan TrentDr. Jonathan C. Trent earned his MD and PhD in cancer biology from The University of Texas Health Science Center where he also completed a residency in internal medicine. He then completed a fellowship in medical oncology at The University of Texas M. D. Anderson Cancer Center while serving as chief fellow. Prior to joining the University of Miami, Sylvester Comprehensive Cancer Center, he held an appointment as associate professor of medicine in the Department of Sarcoma Medical Oncology, Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston. Dr. Trent is currently the Associate Director for Clinical Research, the Director of the Bone and Soft-tissue Sarcoma Group and Medical Director of the Precision Medicine Initiative at the Sylvester Comprehensive Cancer Center.

Dr. Trent’s interests are in the clinical and translational research of sarcomas, direct care of sarcoma patients, and education about sarcoma. As Associate Director for Clinical Research, his goal is to help Sylvester Faculty develop clinical trials that provide clinically effective and scientifically exciting therapy to cancer patients of South Florida and beyond. Dr. Trent is a member of the Pediatric & SDH-Deficient GIST Consortium.

Disclaimer: Information provided in this presentation is not intended as a substitute for your physician’s guidance and care.

LRG Staff
Author: LRG Staff